Profile
Jerry Cacia worked as the Global Head of Pharmaceutical Technical Development at Genentech, Inc. from 1988 to 2016.
He then served as the Head of Biologics & Drug Product Manufacturing at F.
Hoffmann-La Roche Ltd. from 2016 to 2021.
Currently, he is the Chief Technical Officer at Graphite Bio, Inc. since 2021.
Mr. Cacia completed his undergraduate degree at the University of California, Santa Cruz.
Former positions of Jerry Cacia
| Companies | Position | End |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2023 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | - |
Training of Jerry Cacia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
- Stock Market
- Insiders
- Jerry Cacia
















